Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

NARecruitingINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

June 19, 2023

Primary Completion Date

June 19, 2027

Study Completion Date

June 19, 2027

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

COMS One device

The COMS One device incorporates technologies for optical and magnetic stimulation. The optical stimulation component is designed to emit light by two types of light emitting diodes (LEDs) in the wavelength of 660 nm (red) and 830 nm (near infrared) range of the electromagnetic spectra. The magnetic stimulation component is generated by a coil emitting pulse modulated magnetic fields in the extremely low frequency (ELF) range of the electromagnetic spectra. The COMS One is a lightweight, portable device. The device is locally applied via a single use disposable component (COMStouch) that provides a base and sterile barrier for the unit. The device is attached via a single use strap (COMSfix). The device has been slightly adapted in order to make sure blinding is achieved/maintained. The specific feature that has been modified for the purpose of blinding is sensor detecting whether the device is lying on the skin.

DEVICE

Sham device

The Sham device is a lightweight, portable device. The device is applied via a single use disposable component (COMStouch) that provides a base and sterile barrier for the unit. The device is attached via a single use strap (COMSfix). The device has been slightly adapted in order to make sure blinding is achieved/maintained. The specific features that have been modified for the purposes of blinding include the following: 1) therapeutic output, and 2) sensor detecting whether the device is lying on the skin.

Trial Locations (27)

11042

WITHDRAWN

Northwell Comprehensive Wound Healing Center, Lake Success

14215

RECRUITING

Veteran Affairs of WNY Healthcare System, Buffalo

15132

RECRUITING

UPMC McKeesport, McKeesport

27514

RECRUITING

UNC Medical Center, Chapel Hill

30907

RECRUITING

Aiyan Diabetes Center, Augusta

32209

WITHDRAWN

University of Florida Health Jacksonville, Jacksonville

33016

WITHDRAWN

The Angel Medical Research Corporation, Miami Lakes

33126

RECRUITING

Clever Medical Research LLC, Miami

33744

RECRUITING

Bay Pines VA Healthcare System, Bay Pines

37232

RECRUITING

Vanderbilt University Medical Center - Vanderbilt Wound Center, Nashville

43210

RECRUITING

The Ohio State University, Columbus

60611

RECRUITING

Northwestern University Feinberg School of Medicine, Chicago

60612

WITHDRAWN

Rush University, Chicago

62269

RECRUITING

Gateway Clinical Trials, O'Fallon

75208

RECRUITING

Richard C. Galperin DPM PA, Dallas

77004

RECRUITING

HCA Healthcare Houston Medical Center, Houston

78501

RECRUITING

Futuro Clinical Trials, LLC, McAllen

85202

RECRUITING

Titan Clinical Research, Mesa

85723

RECRUITING

Southern Arizona VA Health Care System, Tucson

90010

RECRUITING

Angel City Research, Inc., Los Angeles

90095

RECRUITING

UCLA Ronald Regan - Department of Surgery, Los Angeles

92081

RECRUITING

ILD Research Center, Vista

93710

RECRUITING

Limb Preservation Platform, Inc., Fresno

94115

RECRUITING

Center for Clinical Research Inc., San Francisco

94117

RECRUITING

Center for Clinical Research Inc., San Francisco

94546

RECRUITING

Center for Clinical Research Inc., Castro Valley

07675

RECRUITING

Curalta Clinical Trials, Westwood

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

NAMSA

OTHER

lead

Piomic Medical

INDUSTRY

NCT05758545 - Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers | Biotech Hunter | Biotech Hunter